Table 1.
Variable | Total cohort (n = 70,114) | Survived < 270 days (n = 17,177) | Survived ≥ 270 days (n = 52,937) | ± p-value |
---|---|---|---|---|
Comorbidity index scores | ||||
*Original Liu Comorbidity Index Score (mean ± st. dev.) |
Cannot be calculated |
Cannot be calculated |
7.35 ± 3.99 |
N/A |
**Modified Liu Comorbidity Index Score (mean ± st. dev.) |
6.60 ± 3.75 |
7.30 ± 4.16 |
6.37 ± 3.58 |
<0.0001 |
Demographic and clinical characteristics | ||||
Age (years) (mean ± st. dev.) |
61.5 ± 15.4 |
62.3 ± 16.4 |
61.2 ± 15.1 |
<0.0001 |
Gender (% women) |
56.2% |
53.8% |
57.0% |
<0.0001 |
Race/Ethnicity |
|
|
|
<0.0001 |
Black |
40.3% |
39.0% |
40.8% |
|
Hispanic |
18.0% |
15.8% |
18.8% |
|
Other |
6.0% |
5.2% |
6.2% |
|
White |
35.7% |
40.0% |
34.3% |
|
Employed |
2.5% |
3.2% |
2.3% |
<0.0001 |
Tobacco use |
6.4% |
6.4% |
6.4% |
0.7830 |
Substance abuse |
2.9% |
2.9% |
2.8% |
0.7413 |
Unable to ambulate |
5.8% |
7.9% |
5.2% |
<0.0001 |
Unable to transfer |
2.1% |
3.3% |
1.8% |
<0.0001 |
Home dialysis |
4.9% |
4.6% |
5.0% |
0.0589 |
Body Mass Index |
|
|
|
<0.0001 |
<20 |
10.4% |
12.5% |
9.7% |
|
≥20 to < 24.99 |
30.0% |
31.5% |
29.5% |
|
≥25 to <29.99 |
26.9% |
26.2% |
27.1% |
|
≥30 |
32.8% |
29.9% |
33.7% |
|
Hemoglobin >11 mg/dL |
25.0% |
24.8% |
25.0% |
0.4501 |
Primary renal diagnosis: |
|
|
|
<0.0001 |
Diabetes mellitus |
53.0% |
49.3% |
54.2% |
|
Hypertension |
25.7% |
26.5% |
25.4% |
|
Immune |
7.4% |
7.5% |
7.3% |
|
Other |
14.0% |
16.8% |
13.1% |
|
¶Diabetes mellitus |
62.8% |
60.3% |
63.7% |
<0.0001 |
Congestive heart failure |
34.2% |
37.1% |
33.3% |
<0.0001 |
Coronary artery disease |
25.4% |
27.2% |
24.8% |
<0.0001 |
Cerebrovascular disease |
11.1% |
12.5% |
10.6% |
<0.0001 |
Peripheral vascular disease | 14.8% | 16.6% | 14.3% | <0.001 |
*Original Liu Index captures comorbidity data from days 91–270 after dialysis initiation.
** Modified Liu Index 1–90 captures comorbidity data from days 1–90 after dialysis initiation.
± p-value for bivariate test statistic by survival group.
¶ Diabetes considered present if either noted as the primary cause for renal failure or as a comorbidity in claims data.